KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Sep 2025 value amounting to $1.9 million.

  • Rigel Pharmaceuticals' Other Working Capital Changes rose 34.10% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 24.53%. This contributed to the annual value of $3.4 million for FY2024, which is 267.48% up from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Other Working Capital Changes is $1.9 million, which was up 128.53% from -$6.6 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Other Working Capital Changes high stood at $13.2 million for Q1 2025, and its period low was -$13.9 million during Q2 2021.
  • For the 3-year period, Rigel Pharmaceuticals' Other Working Capital Changes averaged around $895,182, with its median value being -$44,000 (2024).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 3,415.40% in 2021, then skyrocketed by 408.90% in 2025.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Other Working Capital Changes stood at -$508,000 in 2021, then plummeted by 137.99% to -$1.2 million in 2022, then skyrocketed by 370.89% to $3.3 million in 2023, then slumped by 101.34% to -$44,000 in 2024, then spiked by 34.10% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, -$6.6 million for Q2 2025, and $13.2 million during Q1 2025.